International Journal of Gynecological Cancer

Systemic anticancer therapy in gynecological cancer patients with renal dysfunction
pp. 739-763(25)
Authors: LI,; FU,; HU,; LIU,; FINKEL,; GERSHENSON,; KAVANAGH,

The role of regulatory T cells in ovarian cancer
pp. 764-770(7)
Authors: DIETL,; ENGEL,; WISCHHUSEN,

A phase II study of outpatient first-line paclitaxel, carboplatin, and bevacizumab for advanced-stage epithelial ovarian, peritoneal, and fallopian tube cancer
pp. 771-776(6)
Authors: MICHA,; GOLDSTEIN,; RETTENMAIER,; GENESEN,; GRAHAM,; BADER,; LOPEZ,; NICKLE,; BROWN,

Treatment of FIGO stage IV ovarian carcinoma: results of primary surgery or interval surgery after neoadjuvant chemotherapy: a retrospective study
pp. 777-783(7)
Authors: RAFII,; DEVAL,; GEAY,; CHOPIN,; PAOLETTI,; PARAISO,; PUJADE-LAURAINE,

Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)
pp. 784-788(5)
Authors: ALBERTS,; LIU,; WILCZYNSKI,; JANG,; MOON,; WARD,; BECK,; CLOUSER,; MARKMAN,

Ovarian cancer at young age: the contribution of mismatch-repair defects in a population-based series of epithelial ovarian cancer before age 40
pp. 789-793(5)
Authors: DOMANSKA,; MALANDER,; MÅSBÄCK,; NILBERT,

Germ line and somatic mutations of BRAF V599E in ovarian carcinoma
pp. 794-797(4)
Authors: UEDA,; TOJI,; NODA,

The prognostic importance of cyclooxygenase 2 and HER2 expression in epithelial ovarian cancer
pp. 798-807(10)
Authors: STEFFENSEN,; WALDSTRØM,; JEPPESEN,; JAKOBSEN,; BRANDSLUND,

PTEN augments doxorubicin-induced apoptosis in PTEN-null Ishikawa cells
pp. 808-812(5)
Authors: WAN,; LI,; XIE,; LU,

Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors
pp. 813-820(8)
Authors: ATAHAN,; YILDIZ,; OZYAR,; PEHLIVAN,; GENC,; KOSE,; TULUNAY,; AYHAN,; YUCE,; GULER,; KUCUKALI,

Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix
pp. 821-826(6)
Authors: BARNES,; THOMAS,; ACKERMAN,; BARBERA,; LETOURNEAU,; LAM,; MAKHANI,; SANKREACHA,

The histopathologic patterns of cervical lesions and visual inspection with acetic acid on excised uterine cervices
pp. 827-832(6)
Authors: ROCHANAWUTANON,; SRISUPANDIT,

Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study
pp. 833-842(10)
Authors: ATAHAN,; ONAL,; OZYAR,; YILIZ,; SELEK,; KOSE,

Loss of epithelium cadherin expression is associated with reduced overall survival and disease-free survival in early-stage squamous cell cervical carcinoma
pp. 843-850(8)
Authors: DURSUN,; YUCE,; USUBUTUN,; AYHAN,

Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix
pp. 851-857(7)
Authors: HSU,; WANG,; KO,; CHEN,; CHANG,; YANG,; LIN,

The expression of p16 (INK4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins
pp. 858-867(10)
Authors: SONG,; PARK,; EOM,; LEE,; KIM,; HUR,; SAW,

Mutation analysis of the tumor suppressor gene PPP2R1B in human cervical cancer
pp. 868-871(4)
Authors: YEH,; HSIEH,; CHANG,; TSAI,

The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy
pp. 872-878(7)
Authors: YOON,; SHIN,; KIM,; SEO,; PARK,; KANG,; CHO,

Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix
pp. 879-885(7)
Authors: SHARMA,; RAJAPPA,; SAXENA,

Salvage of isolated vaginal recurrences in women with surgical stage I endometrial cancer: a multiinstitutional experience
pp. 886-889(4)
Authors: HUH,; STRAUGHN,; MARIANI,; PODRATZ,; HAVRILESKY,; ALVAREZ-SECORD,; GOLD,; McMEEKIN,; MODESITT,; COOPER,; POWELL,; MUTCH,; NAG,; ALVAREZ,; COHN,

Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer
pp. 890-896(7)
Authors: SUZUKI,; MIYAGI,; TAKAHASHI,; SUKEGAWA,; KOIKE,; SUGIURA,; OKAMOTO,; INOUE,; HIRAHARA,

Hypoxia contributes to development of recurrent endometrial carcinoma
pp. 897-904(8)
Authors: PIJNENBORG,; WIJNAKKER,; HAGELSTEIN,; DELVOUX,; GROOTHUIS,

Estrogen receptor β1 and the β2/βcx isoforms in nonneoplastic endometrium and in endometrioid carcinoma
pp. 905-913(9)
Authors: CHAKRAVARTY,; SRINIVASAN,; GHOSH,; GOPALAN,; RAJWANSHI,; MAJUMDAR,

Endodermal sinus tumor diagnosed in pregnancy: a case report
pp. 914-916(3)
Authors: ROBOVA,; ROB,; HREHORCAK,; ZOBAN,; PRUSA,

Mesothelial pelvic lymph node inclusion in a patient with ovarian microinvasive borderline mucinous tumor: case report with review of the literature
pp. 917-921(5)
Authors: ACIKALIN,; OZALP,; TURAN,

Primary gestational choriocarcinoma of the uterine cervix. Report of a case and review of the literature
pp. 921-925(5)
Authors: KAIRI-VASSILATOU,; PAPAKONSTANTINOU,; GRAPSA,; KONDI-PAPHITI,; HASIAKOS,

Placental site trophoblastic tumor with an ovarian metastasis
pp. 925-927(3)
Authors: MILINGOS,; DOUMPLIS,; SAVAGE,; SECKL,; LINDSAY,; SMITH,

Vaginal tumors with histologic and immunocytochemical feature of gastrointestinal stromal tumor: two cases and review of the literature
pp. 928-933(6)
Authors: NAGASE,; MIKAMI,; MORIYA,; NIIKURA,; YOSHINAGA,; TAKANO,; ITO,; AKAHIRA,; SASANO,; YAEGASHI,

Liquid-based endometrial cytology: its possible value in postmenopausal asymptomatic women
pp. 934-934(1)

Response to letter to the Editor
pp. 935-935(1)

SIOG abstracts
pp. 937-948(12)